Key result
In patients treated invasively for NSTEMI, women experienced a similar rate of in-hospital complications compared to men (30% vs. 26%, p=NS).
Why the study?
Does female sex increase in-hospital complications in patients with Non STEMI treated with PCI?
Cohort (n=479)
No
Does female sex increase in-hospital complications in patients with Non STEMI treated with PCI?
There is no significant gender difference in in-hospital adverse events for patients treated invasively for Non-STEMI, despite women presenting at an older age and with more severe disease.
Answers are grounded in this paper and cite their sources.
Similar complication rates after invasive NSTEMI treatment do not support sex-based treatment withholding; leaves open adjusted risks in contemporary cohorts.
BACKGROUND: To analyze the in-hospital complication rate in women suffering from non-ST elevation myocardial infarction treated with percutaneous coronary intervention (PCI) compared to men. METHODS: The files of 479 consecutive patients (133 women and 346 men) suffering from a Non STEMI (Non ST-segment elevation myocardial infarction) between the January 1st 2006 and March 21st 2009 were retrospectively analyzed with special attention to every single complication occurring during hospital stay. Data were analyzed using nonparametric tests and are reported as median unless otherwise specified. A p value < .05 was considered significant. RESULTS: As compared to men, women were significantly older (75.8 vs. 65.2 years; p < .005). All cardiovascular risk factors but tobacco and hypertension were similar between the groups: men were noticeably more often smoker (p < .0001) and women more hypertensive (p < .005). No difference was noticed for pre-hospital cardiovascular drug treatment. However women were slightly more severe at entry (more Killip class IV; p = .0023; higher GRACE score for in-hospital death - p = .008 and CRUSADE score for bleeding - p < .0001). All the patients underwent PCI of the infarct-related artery after 24 or 48 hrs post admission without sex-related difference either for timing of PCI or primary success rate. During hospitalization, 130 complications were recorded. Though the event rate was slightly higher in women (30% vs. 26% - p = NS), no single event was significantly gender related. The logistic regression identified age and CRP concentration as the only predictive variables in the whole group. After splitting for genders, these parameters were still predictive of events in men. In women however, CRP was the only one with a borderline p value. CONCLUSIONS: Our study does not support any gender difference for in-hospital adverse events in patients treated invasively for an acute coronary syndrome without ST-segment elevation and elevated troponin.
No takes yet. Share an insight, caveat, or question.
Berthillot et al. (2010) conducted a cohort in Non-ST elevation myocardial infarction (NSTEMI) (n=479). Female gender vs. Male gender was evaluated on In-hospital complications (p=NS). In patients treated invasively for NSTEMI, women experienced a similar rate of in-hospital complications compared to men (30% vs. 26%, p=NS).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: